Skip to main content
. 2023 Jul 12;13:1213802. doi: 10.3389/fonc.2023.1213802

Figure 3.

Figure 3

Comparison of NO (A), nitrotyrosine (B), Amadori products (C) concentration between patients with tumours diameter ≤5cm and >5cm; Amadori products (D) and NO (E) level between patients with adenocarcinoma and adenocarcinoma mucinosum; tryptophan (F), and S-nitrosothiols (G) between patients with tumours in G2 and G3 stage; NO (H), kynurenine (I) and N-formylkynurenine (J) between patients with absent and present Helicobacter pylori infection. Adc, adenocarcinoma; Adc muc, adenocarcinoma mucinosum; NO, nitric oxide. *p < 0.05, **p < 0.01, ****p<0.0001.